Kron, A., Alidousty, C., Scheffler, M., Merkelbach-Bruse, S., Seidel, D., Riedel, R., Ihle, M. A., Michels, S., Nogova, L., Fassunke, J., Heydt, C., Kron, F., Ueckeroth, F., Serke, M., Krüger, S., Grohe, C., Koschel, D., Benedikter, J., Kaminsky, B., Schaaf, B., Braess, J., Sebastian, M., Kambartel, K. -., Thomas, R., Zander, T., Schultheis, A. M., Büttner, R., & Wolf, J. (2018). impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer. Annals of oncology, 29, 2068–2075. http://access.bl.uk/ark:/81055/vdc_100095511213.0x00003b